# Brimonidine for Intraoperative Hemostasis

> **NCT05480098** · PHASE4 · WITHDRAWN · sponsor: **University of Louisville**

## Conditions studied

- Dermatochalasis of Eyelid
- Ptosis, Eyelid
- Ectropion
- Entropion

## Interventions

- **DRUG:** Brimonidine Topical

## Key facts

- **NCT ID:** NCT05480098
- **Lead sponsor:** University of Louisville
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-05-26
- **Primary completion:** 2024-05-22
- **Final completion:** 2024-05-22
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Fellow graduated prior to enrollment
- **Last updated:** 2025-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05480098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05480098, "Brimonidine for Intraoperative Hemostasis". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT05480098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*